Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
Results were reported as nmole of glucose and lactate, or pg of insulin
Participants first completed a 60-week open-label weight-loss period on once-weekly tirzepatide at the maximum tolerated dose (10 or 15 mg), achieving a mean weight loss of approximately 20% before randomization
Cold-chain integrity was solid
For retatrutide, the safety database is smaller because the compound is still in Phase 3 trials
Individualized decision-making with your physician is essential
US$ 28.10
US$ 24.61
US$ 21.34
US$ 25.28
US$ 29.46
US$ 23.14
US$ 25.26
US$ 21.82
US$ 25.53
US$ 26.42
US$ 27.01
